MyHealthchecked (MHC)

Sector:

Health Care

Index:

FTSE AIM All-Share

9.75p
   
  • Change Today:
    -0.25p
  • 52 Week High: 27.00
  • 52 Week Low: 8.50
  • Currency: UK Pounds
  • Shares Issued: 52.01m
  • Volume: 4,771
  • Market Cap: £5.07m
  • RiskGrade: 796
  • Beta: 0.03

Concepta successfully launches 'myLotus' in the UK

By Josh White

Date: Monday 17 Dec 2018

LONDON (ShareCast) - (Sharecast News) - Healthcare company Concepta told the market of the successful launch in the UK of its 'myLotus' product for women's fertility on Monday.
The AIM-traded firm explained that myLotus allowed women to self-test to identify their optimal fertile days, thereby improving their chances of naturally getting pregnant.

It said myLotus enabled women to monitor their fertile phase as part of their menstrual cycle, and was the only home test to 'quantitatively' measure personalised hormone levels and the 'rate-of-change' of those levels preceding ovulation, to help aid a natural conception.

Users measured, recorded and tracked their hormone levels, and followed their fertility journey in an accompanying free downloadable app.

Concepta said that while awareness, profile and sales of the myLotus device were commencing, feedback from early users and fertility bloggers had still been "very positive".

Discussions had also commenced with what the company described as 'key opinion leaders' to advise on the wider use of myLotus, especially for women who wished to monitor their hormonal levels, and for those who had previously struggled to conceive naturally, enabling an alternative for couples prior to considering more costly in vitro fertilisation (IVF) treatment.

In addition to the growing myLotus digital UK presence, the company said it was preparing plans for the roll-out of myLotus across Europe under its CE-mark approval.

Commercial discussions had also begun with retail providers, to make myLotus more broadly available across the UK.

"Although marketing and communications around myLotus® are just beginning, feedback from the early users has been exceptional," said Concepta chairman Matthew Walls.

"We will be raising awareness of the value of the myLotus device and its window on fertility over the coming months via an increased online presence, key opinion leaders and marketing of our initial fertility case studies."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

MHC Market Data

Currency UK Pounds
Share Price 9.75p
Change Today -0.25p
% Change -2.50 %
52 Week High 27.00
52 Week Low 8.50
Volume 4,771
Shares Issued 52.01m
Market Cap £5.07m
Beta 0.03
RiskGrade 796

MHC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.78% above the market average90.78% above the market average90.78% above the market average90.78% above the market average90.78% above the market average
93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average
Price Trend
73.76% below the market average73.76% below the market average73.76% below the market average73.76% below the market average73.76% below the market average
13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average
Income Not Available
Growth
30.07% below the market average30.07% below the market average30.07% below the market average30.07% below the market average30.07% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

MHC Dividends

No dividends found

Trades for 01-May-2024

Time Volume / Share Price
08:18 4,771 @ 10.40p

MHC Key Personnel

CEO Penelope McCormick
CFO Lesley Innes

Top of Page